Leukocytoclastic vasculitis in possible relation to the BNT162b2 mRNA COVID-19 vaccine

J Am Geriatr Soc. 2022 Apr;70(4):971-973. doi: 10.1111/jgs.17675. Epub 2022 Feb 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine*
  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • RNA, Messenger
  • Vasculitis, Leukocytoclastic, Cutaneous

Substances

  • COVID-19 Vaccines
  • RNA, Messenger
  • BNT162 Vaccine

Supplementary concepts

  • Erythema elevatum diutinum